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Animal models of disease are an indispensable element in our quest to understand patho-
physiology and develop novel therapies. Ex vivo studies have severe limitations, in particu-
lar their inability to study individual disease progression over time. In this respect, non-
invasive in vivo technologies offer multiple advantages. We here used bilateral common
carotid artery occlusion (BCCAO) in mice, an established model for ischemic retinopathy,
and performed a multimodal in vivo and ex vivo follow-up. We used scanning laser ophthal-
moscopy (SLO), ocular coherence tomography (OCT) and electroretinography (ERG) over
6 weeks followed by ex vivo analyses. BCCAO leads to vascular remodeling with thickening
of veins starting at 4 weeks, loss of photoreceptor synapses with concomitant reduced
b-waves in the ERG and thinning of the retina. Mononuclear phagocytes showed fluctuation
of activity over time. There was large inter-individual variation in the severity of neuronal
degeneration and cellular inflammatory responses. Ex vivo analysis confirmed these vari-
able features of vascular remodeling, neurodegeneration and inflammation. In summary, we
conclude that multimodal follow-up and subgroup analysis of retinal changes in BCCAO fur-
ther calls into question the use of ex vivo studies with distinct single end-points. We propose
that our approach can foster the understanding of retinal disease as well as the clinical
translation of emerging therapeutic strategies.
Introduction
Although there is a rapid and exponential gain in knowledge of basic science, the translation of
experimental results to clinic is still challenging and often fails. For many years, basic animal
research was based on fixed or limited end-point read-outs in disease models although there is
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an urgent need for exploratory studies to understand disease progression. Research aiming to
understand the individual time-course at disease onset, even in animal models, would provide
a very useful insight to research with a high value for clinical translation.
In vivo monitoring and evaluation of pathological parameters are driving recent advances
in animal-based translational research. These parameters are promising biomarkers as they are
often present before the onset of the disease. In research, the retina is a privileged organ
because of its easy optical and electrophysiological accessibility. The retina permits non-inva-
sive, multimodal, and almost simultaneous, analysis of neuronal activity, blood vessel integrity
and micro-structure [1–3] by means of electroretinography (ERG), optical coherence tomog-
raphy (OCT) and laser-scanning ophthalmoscopy (SLO). These methods are routinely used
for diagnostic and prognostic purposes in the clinic. Thus, their use in animal models permits
a correlation of clinically relevant parameters and molecular pathology. Furthermore, these
methods of in vivo analysis allow follow-up studies employing the same animal and thus might
have more of a translational impact.
The benefits of in vivo investigation of the retina are not only limited to the understanding
of ophthalmic disease. Retinal function assessment has become increasingly important in the
investigation of other end-organs such as kidney, heart or brain due to the correlation between
changes in the retina and the development of systemic diseases. New methods to monitor
structure and perfusion of the retina currently employed in the clinic are now also available for
animal models. Thus, evaluation of the potential of multimodal retina analysis is a prerequisite
to fully exploit the possibilities of in vivo assessments in translational research.
We used a mouse model of ischemic retinopathy. Chronic hypoxia leads to retinal damage
and it is a common end-point in multiple systemic and local pathologies [4]. One of the rea-
sons for hypoxia in the retina is blood flow reduction associated to diseases such as carotid
artery disease. This ischemic condition leads to visual impairment. The mouse model selected
has a bilateral common carotid artery occlusion (BCCAO) to mimic chronic hypoperfusion of
the retina and the brain. This model has been traditionally used to understand neurodegenera-
tion in a context of ischemic retinopathy as well as of brain hypoperfusion [5–10]. The focus of
our study is the in vivo follow-up in the retina of the most common neurodegenerative, vascu-
lar and inflammatory features during a time-course of 6 weeks after occlusion. We aim to dis-
cover new features of disease progression, and to combine our findings with observations
from other groups. The multimodal frequent analysis approach will help create a complete pic-
ture of the pathology and to gain insight to patho-mechanisms in BCCAO and in other trans-
lational animal models with varying degrees of impact.
Methods
Animal model and experimental design
All experiments were designed and performed in compliance with the ARVO Statement for
the Use of Animals in Ophthalmic and Vision Research, and approved by the Landesamt fu¨r
Gesundheit und Soziales (LaGeSo, G 0068/12) local authorities. All experiments were in com-
pliance with the ARRIVE guidelines (S1 File).
Male mice underwent coil implantation at the age of 10 weeks, and were housed in 12-hour
light/dark cycle facilities with free access to water and chow. After surgery, animals were regu-
larly checked and a protocol for humane endpoint of the experimental subjects was established
(S2 File). The strains employed in the study were C57/Bl6J (Charles River Erkrath, Germany))
or MacGreen [11] (B6N.Cg-Tg(Csf1r-EGFP)1Hume/J; bred in house) with common genetic
background. Transgenic MacGreen mice were employed in in vivo studies. This strain harbors
an enhanced fluorescent green protein (EGFP) reporter at the site of the Csf1r promoter,
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which is expressed in myeloid-derived macrophages. Both strains were tested negative for RD8
mutation [12].
Animals were evaluated weekly in vivo prior to surgery and after until week 6. Ex vivo read-
outs were performed at week 1 and week 6 after surgery.
Chronic bilateral common carotid artery occlusion
Carotid stenosis was induced wrapping both carotid arteries with micro-coils as described by
Fu¨chtemeier et al. as a model for chronic bilateral common carotid artery occlusion (BCCAO)
and cerebral hypoperfusion [6]. In brief, animals were anesthetized and two small incisions in
the neck allowed the implantation of the micro-coils (N = 42; 180 μm inner diameter, Sawane
Spring Company, Hamamatsu, Japan) on both carotid arteries. Sham animals (N = 28) under-
went the same surgical procedure without micro-coil implantation and served as control.
Scanning laser ophthalmoscopy (SLO) and optical coherence tomography
(OCT)
Pupils were dilated using 2.5% phenylephrin-hydrochlorid and 0.5% tropicamid (Charite´
Apotheke, Berlin, Germany). Anesthesia and subsequent in vivo imaging was performed using
a scanning laser ophthalmoscope Spectralis HRA-OCT (Heidelberg Engineering, Heidelberg,
Germany) as described previously by our group [13]. In short, anesthetized animals were
located at a customized platform attached to the ophthalmoscope with a 30˚ lens. Retina was
investigated: 1) with AF mode (488 nm) before (auto-fluorescence, AF) and after fluorescein
injection (Alcon, Berlin, Germany) for fundus angiography (FAG) or 2) with the mode for
optical coherence tomography (OCT) for retinal thickness studies. All images and retinal
thickness mapping were digitalized using the Heidelberg Eye Explorer software (Heidelberg
Engineering).
Vein-artery ratio analysis
In the angiographs, veins and arteries were identified phenotypically [14]. Vein-artery ratios
were calculated in each individual fundus angiography (26 eyes with BCCAO and 12 control
eyes, 1 image per time-point per eye) in masked fashion by an independent investigator. Mea-
surements were performed using ImageJ (NIH, Bethesda, Maryland, US) setting two concentric
reference circles. The first circle was centered at the optic nerve head (ONH), and the second
circle served to measure the vessel width between the intersection points. The ratio was calcu-
lated from mean (AU) values of the total artery and vein diameter from each photography.
The increase in vein/artery ratio over time was verified ex vivo in flat-mount preparations
at the end point of the experiment (4 affected coil and 3 sham animals).
Eyes were enucleated and fixed in PFA 4% during 15 min. Cornea and lens were gently
removed and discarded. The posterior part of the eye was flattened by doing four radial cuts
and the neural retina was separated from the choroid sectioning the optic nerve. Retina was
blocked using normal goat serum (1 h, RT) and then isolectin-B4 antibody (see Table 1) was
applied overnight at 4˚C. After repeated washes, retina was mounted in a flat position onto a
glass-slide and visualized using a Zeiss Axio Imager (Zeiss, Jena, Germany) and quantified as
the in vivo images.
Quantitative PCR
Eyes were enucleated at the end-point of the experiment (6 weeks) and immediately frozen at
-80˚C. Retina RNA isolation (RNEasy Mini Kit; Qiagen, Hilden, Germany) and cDNA
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synthesis (QuantiTect Reverse Transcription Kit, Qiagen) were carried out according to man-
ufacturer’s instructions. Quantitative real time PCR (qPCR) was done using QuantiTect Sybr
Green PCR Master Mix (Qiagen) on a Rotor Gene Q (Qiagen). All reactions were prepared in
triplicate. The ddCT method was applied to calibrate the target genes and target gene expres-
sion was normalized to GAPDH [15]. Primers are listed in Table 2. For gene expression analy-
sis, only BCCAO animals characterized as affected by means of in vivo data were considered
for analysis.
Immunohistochemistry
Eyes were enucleated, fixed in PFA 4% overnight and embedded in paraffin. Sections of 5 μm
thickness were deparaffinized and stained using standard procedure for H/E or with different
antibodies. Prior to immunodetection, sections were treated with different antigen retrieval
protocols (see Table 1) and blocked with BSA 5% (1 h, RT). Primary antibodies were applied
overnight and detected with species-appropriate fluorescence-conjugated secondary antibod-
ies (1 h, RT; see Table 3). The different antibodies and their dilutions are indicated in Tables 1
and 3. Isotype controls are shown in the S1 Fig. Images were digitalized using a Zeiss Axio
Imager (Zeiss, Jena, Germany) microscope with Apotome, and processed with Zen-Lite 2012
software (Zeiss).
Evaluation of the outer plexiform layer loss
Loss of the outer plexiform layer (OPL) was assessed on sections stained against H/E. 5–10 rep-
resentative sagittal sections per eye were scored to determine the degree of OPL-loss in the ret-
ina. Grade I stands for no structural alterations detected, Grade II has focal alterations in the
OPL (loss of 0–25% of the OPL), Grade III is defined by loss of 25%-50%, Grade IV represents
loss of 50–75% of OPL and Grade V implies a loss from 75–100% of the layer.
Quantification of retinal ganglion cells
Retinal ganglion cells (RGC) were counted manually in masked fashion in representative sagit-
tal sections that contained the ONH. RGC were identified by shape and granularity in H/E
staining. 10–12 visual fields were evaluated and numbers are given as RGC/mm.
Table 1. Primary antibodies.
Antibody against Dilution Unmasking treatment Supplier Cat #
Mouse anti-CALB 1:500 Proteinase K Sigma C9848
Rabbit anti-Caspase 3 1:250 Citrate buffer (pH 6) Cell Signalling 9662
Rabbit anti-Cleaved Caspase 3 1:250 Citrate buffer (pH 6) Cell Signalling 9661
Rabbit anti-CTBP2 1:500 Proteinase K Abcam ab128871
Goat anti-GFP 1:200 None Abcam ab6662
GS Isolectin-B4 1:200 None Invitrogen l21411
Mouse anti-GFP 1:200 None Abcam ab291
Rat anti-CD11b 1:200 None Antibodies online ABIN474860
Rat anti-PlGF 1:100 Proteinase K Abcam ab51654
Rabbit anti-Iba1 1:500 EDTA buffer (pH 9) Wako 01–1974
Rabbit anti-PKCα 1:100 Citrate buffer (pH 6) Santa Cruz sc-208
Rabbit anti-VEGF-A 1:100 Citrate buffer (pH 6) Booster Immuno PA1080
Rabbit anti-VGLUT1 1:250 Citrate buffer (pH 6) Abcam ab104898
https://doi.org/10.1371/journal.pone.0193961.t001
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Electroretinography
Visual function was assessed using Ganzfeld electroretinography (ERG) according to standard
methods as described in our previous works [16]. In short, animals were dark adapted over-
night prior to measurement. Mice with the pupils dilated by 0.5% tropicamide and 2.5% phen-
ylephrine hydrochloride were placed in a Ganzfeld bowl (Roland Consult, Brandenburg,
Germany). Monopolar contact lens electrodes were applied as recording electrodes, and sub-
cutaneously fixed platin needles served as reference electrodes. Scotopic ERG was recorded in
the dark-adapted state. ERG was used to classify the degree of alteration comparing the
BCCAO animals to sham. Animals with statistically significant difference at week 2 after
BCCAO, were considered as “early affected” whereas the rest was kept as “late affected”.
Statistical analysis
All experiments were repeated, at least, three times. The independent unit of observation (N)
was each individual eye, although experimental groups and biometric N were based on





























Table 3. Secondary antibodies.
Antibody against Dilution Supplier Cat #
Donkey anti-Rabbit AF488 1:10000 Invitrogen A-21206
Goat anti-mouse AF546 1:5000 Invitrogen A-11030
https://doi.org/10.1371/journal.pone.0193961.t003
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animals. For all cases, unless indicated the contrary, values are expressed as mean ± SEM. S3
File compiles all numeric results presented in this work in any format. Statistical significance
was calculated using t-test (paired when time-course analysis and unpaired when independent
groups compared at a time-point) or ANOVA when comparing multiple groups. Mann-Whit-
ney U test was applied to determine normal distribution of the data. P value is indicated in the
figures when considered significant and expressed as  when p<0.05,  when p<0.01 and 
when p<0.001.
Bias assessment and bias prevention
Animals were randomized to receive micro-coil implantation (BCCAO group) or not (sham
group). Sample size was determined according to previous publications using this model.
Experiments were performed always at the same time and using the same facilities and equip-
ment for in vivo analysis. Experiments were blind, and analysis was performed blind and often
by other than the investigator that performed the experiment. Some animals died shortly after
surgery or during the time-course of the experiment and were excluded from the study
(N = 10 animals). We also established exclusion criteria depending on the read-out (Table 4).
Results
Retinal vein dilatation in BCCAO
FAG was used to screen the vasculature in vivo weekly after micro-coil implantation (Fig 1A
and 1B). Vascular dynamics were assessed distinguishing veins and arteries and calculating a
relative ratio of the vessel width. Veins started to show dilatation after 3 weeks with BCCAO,
but the vein-artery (V-A) ratio was significantly altered only 6 weeks after coil (Fig 1C).
Among coiled animals there was a high variability in the degree of impact. A low percentage of
BCCAO individual retinas (15%) did not show any vascular changes and behaved like sham
controls. Furthermore, we classified as mild or severe vein dilatation in terms of absolute V-A
ratio numbers, although the dynamics of the alteration were analogous (Fig 1C). Ex vivo data
on retinal flat-mounts stained against Isolectin-B4 verified structural dilation of the veins (S2
Fig).
Using qPCR of retinal tissue, several markers associated with angiogenesis and vascular
remodeling supported the previous findings. RNA levels of the ligand placenta growth factor
(Plgf) were upregulated (Fig 1D), whereas vascular endothelial growth factor (Vegf)-a and -b
only showed a trend of increase (Fig 1E and 1F). The receptors Fms-related Tyrosine Kinase 1
(Flt1) and its soluble form (sFlt1) RNA levels were significantly upregulated in the retina 6
weeks after BCCAO (Fig 1G and 1H).




1. Cataract formation or opacity of the cornea/lens that does not allow reliable
imaging after anesthesia.
2. Low quality of the image (e.g. blurriness, low edge sharpness).
Electroretinography (ERG) 1. No signal detected or delocalization of the electrodes.
2. Animals moved or died during ERG recording.
Immunohistochemistry 1. Tissue folds or excessive artefacts after histological processing.
Retinal whole-mounts 1. Loss of integrity of the tissue during retinal processing.
qPCR 1. Low quality of the RNA/DNA (260/280 ratio below 1.7).
https://doi.org/10.1371/journal.pone.0193961.t004
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Fig 1. Vascular dynamics in the retina after BCCAO. A. Time-course of fundus angiographies after BCCAO (A) or sham intervention (B). Arrows
point to (dilated) veins. C. Left: Representative fundus angiographies depicting arteries (A) and veins (V). Right: Bar chart represents the V-A ratio of
Temporal changes in vivo of the retina after BCCAO
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Time-course of distribution of mononuclear phagocytes in the retina
Inflammation was explored in vivo using MacGreen mice to monitor mononuclear phagocytes
(MPs). Auto-fluorescence images were taken weekly and showed dynamic changes in the dis-
tribution of MPs as well in their activation state in the retina (Fig 2A, S1 Video). Remarkably,
animals with micro-coil showed MP mobilization/accumulation surrounding veins (Fig 2A,
dashed-lined area). The differences in the pattern of MP distribution, however, occurred at dif-
ferent time-points: some animals showed the dynamic changes rapidly at the same week after
the coil implantation, whereas others did 3 weeks after (S1 Video). All animals with BCCAO
showed alterations in vivo regarding MP turnover. MPs were accumulated surrounding the
ONH area at the end-point of the experiment (Fig 2A, Week 6).
After BCCAO, RNA levels of several genes related to inflammation and MPs were upregu-
lated in the retina: Il6, Cd68 and Ccl2. Il1b, Il4r and Tnfa, however, did not show significant dif-
ferences (Fig 2B).
Differential temporary changes in visual function and grades of alteration
Ganzfeld ERG was applied to assess retinal function. Under scotopic conditions, sham animals
showed a physiological response curve with normal amplitudes for a-wave, b-wave and oscil-
latory potentials. No significant changes could be detected in control animals during the
6-week time-course after surgery (Fig 3A). In BCCAO conditions, however, the time course
and the reduction of the different amplitudes of the curve was variable: some of the animals
showed a mild reduction of the amplitudes at late stages after the micro-coil implantation
(W4) and are referred as late affected (Fig 3B), whereas another group of animals showed an
early and stable amplitude decrease in the first week after the surgery (W1) and we classified
them as early affected (Fig 3C).
Altogether, a decrease in a-wave (Fig 3D), b-wave (Fig 3E) amplitudes was observed
between sham and BCCAO animals, becoming significant at W2 for the early affected and at
W4 for the late affected, respectively. B-a-ratio was significantly reduced at W4 in both
BCCAO groups compared to sham (Fig 3F). Early affected animals showed significantly
smaller amplitudes of oscillatory potentials already at W1, whereas late affected showed that
feature one week after (Fig 3G). The decrease of oscillatory potentials is an indirect evidence
for hypoxia in the retina. Protein expression of hypoxia-inducible factor 1-alpha (HIF-1α) in
the retina of animals after 1 week (W1) with BCCAO further supported this finding (S3 Fig).
Structural changes of the retinal layers
Retinal structure was evaluated systematically 1 and 6 weeks after BCCAO: 1) ex vivo in H/E
sagittal sections and 2) in vivo with OCT retinal thickness mapping.
In H/E stained sections, a loss of the OPL was observed. The extent of loss of OPL varied
among the animals with BCCAO, and sometimes even the adjacent nuclear layers such as the
inner nuclear layer (INL) were affected (Fig 4A and 4B). We did not observe significant differ-
ences in numbers of RGC in coil compared to sham. BCCAO (N = 6 animals) presented 90
RGC/mm whereas sham (N = 3 animals) had 94 RGC/mm (p = 0.833). Using OCT retinal
thickness mapping multiple retinal regions were identified indicating a significant thinning of
the retina in coil after 6 weeks of BCCAO (Fig 4C, blue areas and S4 Fig). Sham did not show
relevant variations in thickness (Fig 4C and S4 Fig).
the distinct groups (BCCAO vs. sham) during the time-course. D-H. Bar charts represent differential RNA expression of angiogenic markers in retinal
tissue.
https://doi.org/10.1371/journal.pone.0193961.g001
Temporal changes in vivo of the retina after BCCAO
PLOS ONE | https://doi.org/10.1371/journal.pone.0193961 March 16, 2018 8 / 18
The degree of loss of OPL was different among the animals that had coil implantation. Reti-
nas were evaluated ex vivo and graded according to the percentage of OPL loss (Fig 4D). 1
week after coil implantation, only 10% of individual retinas showed structural changes of the
Fig 2. Inflammatory dynamics in the retina after BCCAO. A. Time-course of fundus auto-fluorescence of MacGreen mouse after BCCAO. EGFP signal corresponds
to myeloid cells. Marked regions (dashed lines in red) show clusters of mononuclear phagocytes. B. Bar charts represent differential RNA expression of inflammatory
markers of retinal tissue.
https://doi.org/10.1371/journal.pone.0193961.g002
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OPL (Fig 4D, Week 1), although at week 6 most of the animals varied to a bigger or smaller
extent (Fig 4D, Week 6). 25% of evaluated retinas with BCCAO did not show any loss of OPL.
Fig 3. Analysis of temporal changes in visual function using Ganzfeld ERG. A-C. Graphs show representative curves of Ganzfeld ERG during the experimental time-
course of a (A) sham, (B) late affected BCCAO and (C) early affected BCCAO animals. D. Scotopic a-wave. E. Scotopic b-wave. F. b/a-wave ratio. G. Oscillatory
potentials.
https://doi.org/10.1371/journal.pone.0193961.g003
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Mu¨ller cells were studied as one of the main cell types contributing to retinal structure
integrity. Using glial fibrillary acidic protein (GFAP), however, remarkable gliosis of the retina
was observed compared to sham controls (Fig 4E).
Synaptic changes in the neural retina
Synaptic proteins were evaluated in order to assess if they were affected by the loss of OPL at
different time-points after coil implementation.
Retinal sagittal sections were stained with antibodies against vesicular glutamate transporter
1 (VGLUT1). VGLUT1 is associated with the membranes of synaptic vesicles and was used to
detect the pre-synaptic site of the photoreceptor bipolar synapse. 1 week after BCCAO,
VGLUT1 expression was disorganized compared to that in controls. This delocalization per-
sisted 6 weeks after (Fig 5A).
C-terminal-binding protein 2 (CTBP2), which is a component of synaptic ribbons, served
as another marker for the pre-synaptic site. Coil animals revealed delocalization and loss of
CTBP2 expression at W6, whereas at W1 the staining pattern was still comparable to sham ani-
mals that presented an intense signal along the presynaptic site of the OPL (Fig 5B).
Fig 4. Structural changes in the retina after BCCAO. A. Representative sagittal sections of the eye stained with H/E showing the retinal layers in a control eye. B.
Representative sagittal sections of the eye stained with H/E showing structural alterations in the retinal layers 1 and 6 weeks after BCCAO. Scale bar on
magnification = 100 μm; Scale bar on full retina = 500 μm. Black arrows indicate the retina. C. OCT retinal mapping of representative sham and BCCAO animals.
Colorimetric scale indicates retinal thickness. D. Pie charts show distribution of the animals 1 or 6 weeks after BCCAO according to loss of the outer retinal layer (OPL).
Grading is indicated in the figure according to percentages in OPL loss. E. Representative sagittal sections of the retina co-stained against GFAP (green) and VIM (red)
showing Mu¨ller cells. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm.
https://doi.org/10.1371/journal.pone.0193961.g004
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Bipolar cells were detected using an antibody against Protein kinase C α (PKCα). PKCα
staining helps to identify the post-synaptic site of the synapse of photoreceptors and bipolar
cells. PKCα staining revealed dislocalization and loss of arborization of the bipolar cells after
BCCAO already after 1 week. (Fig 5C).
Horizontal cell loss was detected in animals with micro-coil one week after BCCAO using
Calbindin-D28k (CALB) staining (Fig 5D).
Discussion
Several diseases lead to visual impairment through ischemia. BCCAO is an established model
for ischemic retinopathy that reproduces neurodegenerative features after blood flow reduc-
tion [4,17]. Most previous studies employed Wistar rats with complete ligation of the common
carotid artery whereas we used a micro-coil in mice. This leads only to minor reduction in
blood flow in the brain by approx. 20% [6]. Furthermore, previous studies focused mainly on
the analysis of structural retinal alterations (e.g. thinning of the retina after 1 week to 2 months
of artery ligation) [8,10,18,19]. Although in the literature RGC loss has been described as early
as week 1 after BCCAO [8,18], we did not detect loss of RGC during the time course. Existent
literature is only in rat models, but we believe that the extent of vessel occlusion, and thus
Fig 5. Delocalization of synaptic markers in the retina after BCCAO. A. Representative sagittal sections of the retina stained against VGLUT1 (green) showing loss
and delocalization of pre-synaptic proteins in animals with BCCAO. B. Representative sagittal sections of the retina stained against CTBP2 (red) showing loss and
delocalization of pre-synaptic proteins. C. Representative sagittal sections of the retina stained against PKCα (green) showing loss and delocalization of post-synaptic
proteins after prolonged BCCAO. D. Representative sagittal sections of the retina stained against CALB (red) showing loss horizontal cells in coiled animals. All nuclei
were counterstained with DAPI (blue). For all cases, scale bar = 50.
https://doi.org/10.1371/journal.pone.0193961.g005
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hypoperfusion, might explain these discrepancies. In our model, we were also able to reproduce
most of the findings regarding Mu¨ller cell gliosis, loss of horizontal cells and loss of synaptic
protein [10,20,21]. Previous studies already described alterations in the OPL after BCCAO
[8,10,20,21]. We provide additional structural details by determining delocalization or loss of
OPL in terms of pre- and post-synaptic proteins. These findings were supported functionally by
means of ERG. Here we detected a strong reduction in the b-wave, representing bipolar cell
activity, in relation to the a-wave that represents the photoreceptor activity and was only minor
affected in BCCAO. On the functional level, these data indicate a reduction in the signal transfer
from the photoreceptors to the second neuron, the bipolar cells that correlates with a loss of
photoreceptor synapses. Most works focus on the impact of BCCAO on retinal neurons, but
there is not much data on vascular remodeling and inflammation concomitant to ischemia in
this model. We showed dynamics of vein dilation in the time-course after BCCAO in vivo. Dif-
ferential gene expression of angiogenic markers in affected animals furthermore supported
these findings. Since BCCAO is primarily a vascular dementia model, the brain is clearly
affected by the intervention. Both cerebral blood flow as well as behavioral and structural alter-
ations are detectable in mice after BCCAO [6]. The loss of synapses that we detected in the neu-
ral retina, however, has not been assessed in brain sections of different areas yet.
Although it is of common sense that ischemia and inflammation are two related pathologi-
cal processes, we have been the first to monitor the distribution and activation of MPs in vivo.
Additionally, we provide evidences of differential gene expression regarding macrophage
recruitment.
So far, animal models for retinal vascular and neurodegenerative disease were studied by
analyzing only selected endpoints during the progression of the pathology [22–24]. Further-
more, for many of the cases these analyses have been done ex vivo.
SLO, OCT or ERG are in vivo non-invasive methods, affordable for most laboratories, and
can be easily combined with transgenic models. Data acquisition in vivo has the advantage to
enable follow-up studies using the same subject and thus minimizing the number of experi-
mental animals.
The traditional approach with few fixed time-points defined by previous knowledge of time
courses, nonetheless, might be useful for models with a well-characterized and established dis-
ease phenotype in a rather short lapse. One illustrative example is the laser-induced choroidal
neovascularization [25], which is an acute model for wet age-related macular degeneration.
However, most models that focus more on chronic aspects of diseases cannot be determined
in such a short time scale and rigid manner. With our approach to analyze this chronic model
weekly, we demonstrated that just few time-points do not deliver a full picture of the dynamic
changes of the retina that might be critical for the understanding of the progression of the dis-
ease and for identification of critical points of intervention. Previous works in BCCAO only
presented a small insight in the in vivo strategies to analyze the retina. Some groups explored
the BCCAO model with total occlusion using ERG, but only acutely (14 days after occlusion).
Their results are in accordance with our data [5,26,27]. Huang and colleagues analyzed the ret-
ina by means of FAG after 3 weeks of BCCAO in rats, and observed vein dilatation, increasing
tortuosity and blurring of the optic disc, but only qualitatively [7].
Based on our data, we detected general patterns with differences in terms of severity and
onset of the pathological changes after BCCAO. Albeit this variability hampers the statistical
analysis, we detected significant differences even in composite analysis, revealing a high degree
of robustness of the data. Findings presented important temporal differences between individ-
uals undergoing the same treatment and, interestingly, even intra-individually among contra-
lateral eyes. Thus, variability is a key parameter to determine the degree of alteration and to
understand the effect of hypoperfusion of the retina in a model such as BCCAO.
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For instance, vein dilatation does not follow a linear progression: there are hints of dilata-
tion early after micro-coil implantation in some individuals classified as “severe”, as Huang
and colleagues described [7], although later it fluctuates. Other less affected animals, showed
same features with a lower degree of severity, and one-third group did not show pathological
changes at all. Using auto-fluorescence measurements in MacGreen mice, we also showed how
the distribution and activation of MPs in the retina is highly variable during the time-course of
BCCAO among the individuals: after implantation of the micro-coil, only some mice showed
MPs mobilization and clustering and, 2 weeks after, they switched to a quiescent state. At week
4, a second phase of activation occurred reaching a high degree of accumulation in the ONH
area at week 6. This inflammatory phenomenon appeared with a delay of weeks in other ani-
mals. Oscillatory potentials diminished one week after BCCAO and hint to the ischemic state
of the retina, but only after 4 weeks, we found a decrease in the a- and b-waves, suggesting
damage in the photoreceptors and bipolar cells respectively. Immunohistochemistry data veri-
fied these findings and these are in accordance with other works published as argued above. It
is interesting to note that photoreceptors appeared more affected compared to the neurons of
the inner retina. This could be an effect of a differential reduction in the blood flow between
the choroidal and the retinal circulation. However, no specific data exist that describe the pro-
portion of blood flow between the retinal and choroidal perfusion. Moreover, it seems that
there are intersections between the optic nerve, retinal and choroidal blood supply with strong
individual variations [28]. Given the estimation of blood flow reduction in the central nervous
system by 15%, we argue the same effects for both retinal and choroidal circulation. Thus, we
are not able to deliver a concluding explanation for the primal affection of the photoreceptor
synapse by a differential blood flow reduction between retinal and choroidal circulation.
The above described inter- and intra-individual variability in both, onset and severity of
alteration, demonstrates that factors beyond genetics can have major impact on disease pheno-
type of this model. As these animals are inbred, and we used highly standardized experimental
approaches performed by well-trained surgeons and experimentalists, minor variations in
experimental conditions, housing, handling, etc. seem to affect our model. While such experi-
mental variability may seem as a nuisance, it probably reflects the clinical condition in of
inter- and intra-individual disease progression and response to therapy.
In vivo monitoring over the entire time span of an experiment not only reveals such vari-
ability, but may also help to understand individual disease progression and therefore improve
bench to bedside translation.
BCCAO is a model that has not been only used for investigation of hypoxic impact onto the
retina but also onto the brain. The BCCAO impacts onto the retina point to another confound-
ing effect when using this model in behavioral tests for brain research. Our data lead us to the
conclusion that BCCAO leads to blindness at variant time points from blindness of very early
onset to mild effects after 6 weeks. The blindness develops by an interruption of synaptic con-
nection between photoreceptors and bipolar cells. Blindness might confound behavioral test-
ing of higher brain functions. Thus, in BBCAO ERG recording should be correlated with
behavioral tests.
BCCAO calls for caution in drawing conclusions: limited experimental read-outs might
lead to interpretation bias. Especially, translation medicine should consider individual time-
courses and subgroups to approach therapeutic or interventional studies. Personalized medi-
cine is something demanded in the clinic but, often, forgotten in basic research.
Our data have implications not only for the BCCAO model but also for the use of the new
upcoming techniques in in vivo analysis models in basic translational research. In BCCAO,
fixed time points for analysis might lead to wrong or contradictory conclusions. For the use of
the variety of new in vivo analysis technologies, we demand to exploit fully their advantages
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and opportunities. These are multimodal analysis, close correlation with clinical assessments
and follow-up studies; the latter one also reduces the number of animals in a study.
Supporting information
S1 Fig. Immunohistochemistry isotype controls. A-B. Sagittal sections of the retina stained
against the secondary antibodies indicated in Table 3. Staining served as negative controls.
Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm.
(TIF)
S2 Fig. Vein-artery ratio supplement. A. Representative retinal flat-mount stained against
isolectin-B4. Representative artery “A” and vein “V” are indicated in the figure. Scale
bar = 100 μm. B. Plot with the differences in vein-artery ratio.  indicates p<0.01.
(TIF)
S3 Fig. HIF1α in the retina. A-C. Representative sagittal sections of the retina stained against
HIF1α (red) in (A) sham and BCCAO (B) 1 week and (C) 6 weeks after implantation. Nuclei
were counterstained with DAPI (blue). Scale bar = 50 μm.
(TIF)
S4 Fig. Retinal thickness mapping supplement. A. Colorimetric grading of retinal thickness
in a sham and BCCAO animals. Images were obtained using Eye Heidelberg software and are
supplementary to the ones displayed in Fig 4C without infra-reflectance background. B. Rep-
resentative OCT used by the software to create the retinal thickness maps in a sham and a
BCCAO animal. The OCT image shows differences in layer thickness. Red line displayed in
the images represents the area selected for thickness mapping.
(JPG)
S1 Video. Dynamic time-course of fundus auto-fluorescence of representative MacGreen
mouse sham and after BCCAO (early and late affected animals). EGFP signal (white) corre-
sponds to myeloid cells. Red arrowheads point activated mononuclear phagocytes.
(MP4)
S1 File. ARRIVE guidelines checkpoint list. Checklist of aspects related to animal research in
in vivo experiments.
(PDF)
S2 File. Plos one humane checklist endpoints. Checklist of aspects from the study design
which include death of a regulated animal as a likely outcome or planned experimental end-
point.
(PDF)
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